Quantitation phase cells primary carcinomas Antibody subunit ribonucleotide reductase phase restriction point block Human cancers apparent low growth fraction bulk cells cycle quiescent state due inability past cells allosteric subunit ribonucleotide reductase cells transition exit distinguishes cells proportion cells primary human breast colorectal adenocarcinomas analytical DNA flow cytometry ADFC immunoperoxidase staining sections monoclonal antibody MAb ADFC fresh tumors low percentage cells phase immunoperoxidase staining high proportion positive cells high content primary human tumors human cancers transition quiescent state block human cancers regulatory events restriction point phase relative growth factor deficiency density inhibition antiproliferative cytokines gene products flow cytometry DNA content human colon cancer cell lines phase serum deprivation density inhibition human breast cancer cell lines phase medroxyprogesterone acetate MPA tamoxifen exposure findings situ observations concept restriction point block primary human tumors 